Ownership

Kyle Gano - Chief Executive Officer, Director at Neurocrine Biosciences Inc

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Executive Officer, Director
Stock Symbol: NBIX on Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
All Insider Reports: All Insider Reports

Kyle Gano - trading volume in the past year for Neurocrine Biosciences Inc

	Shares	%	Avg Price	Total $
Buys
Sells	-80.5K	100%	$131.92	-$10.6M
Net	-80.5K	-100%		-$10.6M

Holdings reported by Kyle Gano for Neurocrine Biosciences Inc

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	135K	$18M	$132.89	Feb 13, 2024	Direct
Restricted Stock Unit	8.97K	$1.19M	$133.03	Feb 13, 2024	Direct	Common Stock
Restricted Stock Unit	2.46K	$194K	$79.02	Nov 1, 2024	Direct	Common Stock
Stock Option	45.1K			Feb 13, 2024	Direct	Common Stock
Stock Option	13.3K			Nov 1, 2024	Direct	Common Stock
Incentive Stock Option	0		$19.59	Jan 2, 2024	Direct	Common Stock
Non-Qualified Stock Option	0		$79.02	Jan 2, 2024	Direct	Common Stock

Transactions reported by Kyle Gano for Neurocrine Biosciences Inc

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.